Cannabics Pharmaceuticals Investors
Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) is a U.S. public company and a global leader in the development of cancer related cannabinoid-based medicine. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer.
Headquarters:
Bethesda, Maryland, United States
Industry:
Biotechnology, Health Care, Science and Engineering
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Investor Type:
Not Classified
Funding Status:
IPO
Number Of Exists:
1
Last Funding Type:
Undisclosed
Founded Date:
2012-03-21
Total Funding:
3000000 USD
Last Funding Date:
2017-05-06